191 related articles for article (PubMed ID: 37288489)
1. Latest classification of ependymoma in the molecular era and advances in its treatment: a review.
Yamaguchi J; Ohka F; Motomura K; Saito R
Jpn J Clin Oncol; 2023 Jul; 53(8):653-663. PubMed ID: 37288489
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.
Witt H; Gramatzki D; Hentschel B; Pajtler KW; Felsberg J; Schackert G; Löffler M; Capper D; Sahm F; Sill M; von Deimling A; Kool M; Herrlinger U; Westphal M; Pietsch T; Reifenberger G; Pfister SM; Tonn JC; Weller M;
Neuro Oncol; 2018 Nov; 20(12):1616-1624. PubMed ID: 30053291
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Ependymoma.
Vitanza NA; Partap S
J Child Neurol; 2016 Oct; 31(12):1354-66. PubMed ID: 26503805
[TBL] [Abstract][Full Text] [Related]
4. Current therapy and the evolving molecular landscape of paediatric ependymoma.
Khatua S; Ramaswamy V; Bouffet E
Eur J Cancer; 2017 Jan; 70():34-41. PubMed ID: 27866097
[TBL] [Abstract][Full Text] [Related]
5. Advances in Management of Pediatric Ependymomas.
Lin FY; Chintagumpala M
Curr Oncol Rep; 2015 Oct; 17(10):47. PubMed ID: 26369328
[TBL] [Abstract][Full Text] [Related]
6. Advances in the classification and treatment of pediatric brain tumors.
Fangusaro J; Bandopadhayay P
Curr Opin Pediatr; 2021 Feb; 33(1):26-32. PubMed ID: 33278109
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology of paediatric central nervous system tumours.
Chiang JC; Ellison DW
J Pathol; 2017 Jan; 241(2):159-172. PubMed ID: 27701736
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in the Classification and Treatment of Ependymomas.
Leeper H; Felicella MM; Walbert T
Curr Treat Options Oncol; 2017 Aug; 18(9):55. PubMed ID: 28795287
[TBL] [Abstract][Full Text] [Related]
9. Ependymoma: Evaluation and Management Updates.
Rudà R; Bruno F; Pellerino A; Soffietti R
Curr Oncol Rep; 2022 Aug; 24(8):985-993. PubMed ID: 35384591
[TBL] [Abstract][Full Text] [Related]
10. Genetic expression profiles of adult and pediatric ependymomas: molecular pathways, prognostic indicators, and therapeutic targets.
Nagasawa DT; Trang A; Choy W; Spasic M; Yew A; Zarinkhou G; Garcia HM; Yang I
Clin Neurol Neurosurg; 2013 Apr; 115(4):388-99. PubMed ID: 23374238
[TBL] [Abstract][Full Text] [Related]
11. Intracranial ependymomas of childhood: current management strategies.
Smyth MD; Horn BN; Russo C; Berger MS
Pediatr Neurosurg; 2000 Sep; 33(3):138-50. PubMed ID: 11096361
[TBL] [Abstract][Full Text] [Related]
12. Management of Ependymoma in Children, Adolescents and Young Adults.
Thorp N; Gandola L
Clin Oncol (R Coll Radiol); 2019 Mar; 31(3):162-170. PubMed ID: 30616927
[TBL] [Abstract][Full Text] [Related]
13. Intracranial ependymomas: molecular insights and translation to treatment.
Lester A; McDonald KL
Brain Pathol; 2020 Jan; 30(1):3-12. PubMed ID: 31433520
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system ependymoma: clinical implications of the new molecular classification, treatment guidelines and controversial issues.
Delgado-López PD; Corrales-García EM; Alonso-García E; García-Leal R; González-Rodrigálvarez R; Araus-Galdós E; Martín-Alonso J
Clin Transl Oncol; 2019 Nov; 21(11):1450-1463. PubMed ID: 30868390
[TBL] [Abstract][Full Text] [Related]
15. Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma.
Tabori U; Wong V; Ma J; Shago M; Alon N; Rutka J; Bouffet E; Bartels U; Malkin D; Hawkins C
Br J Cancer; 2008 Oct; 99(7):1129-35. PubMed ID: 18797459
[TBL] [Abstract][Full Text] [Related]
16. Pediatric ependymomas: will molecular biology change patient management?
Grill J; Bergthold G; Ferreira C
Curr Opin Oncol; 2011 Nov; 23(6):638-42. PubMed ID: 21892086
[TBL] [Abstract][Full Text] [Related]
17. Ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic options.
Dorfer C; Tonn J; Rutka JT
Handb Clin Neurol; 2016; 134():417-31. PubMed ID: 26948369
[TBL] [Abstract][Full Text] [Related]
18. [Pediatric ependymomas: Current diagnosis and therapy].
Frappaz D; Vasiljevic A; Beuriat PA; Alapetite C; Grill J; Szathmari A; Faure-Conter C
Bull Cancer; 2016 Oct; 103(10):869-879. PubMed ID: 27717499
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of histopathological ependymoma variants.
Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
[TBL] [Abstract][Full Text] [Related]
20. Put away your microscopes: the ependymoma molecular era has begun.
Mack SC; Taylor MD
Curr Opin Oncol; 2017 Nov; 29(6):443-447. PubMed ID: 28885433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]